Acadia Healthcare Company, Inc. ACHC

28.09 0.29 1.04% as of 25 Sep
Market cap
$2.6B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
2,810.91 2,836.32 1,904.70 2,008.38 2,089.93 2,314.39 2,610.40 2,928.74 3,153.96 3,312.77
Revenue Growth
56.64% 0.90% (32.85%) 5.44% 4.06% 10.74% 12.79% 12.20% 7.69% 5.04%
Gross Profit
2,810.91 2,836.32 1,904.70 2,008.38 2,089.93 2,314.39 2,610.40 2,928.74 3,153.96 3,312.77
SG&A Expenses
1,844.77 1,846.82 1,240.83 1,311.34 1,362.25 1,471.25 1,651.65 1,854.34 1,993.44 2,134.23
Operating Income
445.14 437.88 305.54 314.09 365.61 414.47 467.69 513.02 522.28 387.96
Non-operating Income/Expense
(412.19) (201.08) (238.14) (235.70) (181.81) (138.71) (93.55) (538.37) (180.40) (1,453.91)
Non-operating Interest Expenses
181.33 176.01 184.53 187.33 158.11 76.99 69.76 82.13 116.37 138.86
EBT
32.96 236.80 67.40 78.40 183.80 275.76 374.14 (25.36) 341.88 (1,065.94)
Income Tax Provision
28.78 37.21 9.91 25.09 40.61 67.56 94.11 (9.70) 77.40 25.98
Income after Tax
4.18 199.59 57.49 53.31 143.19 208.20 280.03 (15.66) 264.48 (1,091.92)
Dividends (Preferred)
— — — 0.00 0.00 — 0.00 — 0.00 —
Non-Controlling Interest
(1.97) (0.25) 0.26 1.20 2.93 4.93 6.89 6.01 8.87 10.85
Net Income Common
6.14 199.84 (175.75) 108.92 (672.13) 190.64 273.14 (21.67) 255.61 (1,102.77)
EPS (Basic)
0.07 2.30 (2.01) 1.24 (7.65) 2.15 3.05 (0.24) 2.79 (12.16)
EPS (Diluted)
0.07 2.30 (2.01) 1.24 (7.59) 2.10 2.98 (0.24) 2.78 (12.16)
Shares (Basic, Weighted)
85.70 86.95 87.29 87.61 87.88 88.77 89.68 90.95 91.62 90.71
Shares (Diluted, Weighted)
85.97 87.06 87.42 87.82 88.60 90.79 91.56 90.95 92.06 90.71
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBIT Margin
15.84% 15.44% 16.04% 15.64% 17.49% 17.91% 17.92% 17.52% 16.56% 11.71%
EBT margin
1.17% 8.35% 3.54% 3.90% 8.79% 11.91% 14.33% (0.87%) 10.84% (32.18%)
Net Profit Margin
0.22% 7.05% (9.23%) 5.42% (32.16%) 8.24% 10.46% (0.74%) 8.10% (33.29%)
Free Cash Flow Margin
0.47% 3.16% 7.48% 5.58% 20.76% 5.75% 3.50% 2.31% (17.45%) (12.56%)
EBITDA
590.57 590.75 396.34 414.00 473.50 525.26 588.72 648.69 675.96 582.08
EBIT
445.14 437.88 305.54 314.09 365.61 414.47 467.69 513.02 522.28 387.96
Income from Continuous Operations
4.18 199.59 57.49 53.31 143.19 208.20 280.03 (15.66) 264.48 (1,091.92)
Income from Discontinued Operations
— — (232.97) 56.81 (812.39) (12.64) — — — —
Consolidated Net Income/Loss
4.18 199.59 (175.49) 110.12 (669.20) 195.56 280.03 (15.66) 264.48 (1,091.92)
EPS (Basic, from Continuous Ops)
0.05 2.30 0.66 0.59 1.60 2.29 3.12 (0.17) 2.89 (12.04)
EPS (Basic, from Discontinued Ops)
— — (2.67) 0.65 (9.25) (0.14) — — — —
EPS (Basic, Consolidated)
0.05 2.30 (2.01) 1.26 (7.62) 2.20 3.12 (0.17) 2.89 (12.04)
EPS (Diluted, from Cont. Ops)
0.05 2.29 0.65 0.59 1.58 2.24 3.06 (0.17) 2.87 (12.04)
EPS (Diluted, from Disc. Ops)
— — 0.00 0.00 0.00 0.00 — — — —
Shares (Diluted, Average)
85.97 87.06 87.29 87.82 88.60 90.79 91.56 90.95 92.06 90.71
EPS (Diluted, Consolidated)
0.05 2.29 (2.01) 1.25 (7.55) 2.15 3.06 (0.17) 2.87 (12.04)
EBITDA Margin
21.01% 20.83% 20.81% 20.61% 22.66% 22.70% 22.55% 22.15% 21.43% 17.57%
Operating Cash Flow Margin
12.86% 14.09% 21.74% 16.58% 31.52% 16.18% 14.58% 15.79% 4.11% 3.98%

Fold the line items

In millions of $ except per-share values · columns are period end dates